Eye Yoga, Glaucoma
Conditions
Brief summary
The aim of the trial is to investigate the possibilities of improving visual impairments with eye training exercises (eye-yoga) in a total of 40 patients with glaucoma who have not previously been treated within a similar training program. 20 patients will be instructed how to do eye yoga to be performed dails for 4 weeks (max 30 min/day). As a control group of 20 patients will be instructed to read for 30 min/day for 4 weeks. The following outcome measures will be investigated: High Resolution Perimetry, Humphrey Perimetry, Visual Acuity Test, Contrast Sensitivity Test, Microsaccades measurements, Intraocular Pressure Measurement, Electroencephalogram (EEG), Blood Pressure and Pulse Measurement and Dynamic Vessel Analysis (DVA - the blood supply in the eye (especially vascular dysregulation) . Furthermore, factors that could influence response variability and the effectiveness of treatment will be analysed: (i) the role of mental stress (or stress resilience) and (ii) the influence of personality traits and quality of life. The study is intended to further validate this home training program (eye yoga) for the treatment of visual impairment in glaucoma.
Detailed description
The aim of eye yoga is to improve microsaccade impairments in patient with primary open angle glaucoma. We will study how this affects visual performance and the physiology of the eye and brain
Interventions
BEHAVIORALEye yoga
Eye yoga exercises at home given by a trained instructor
BEHAVIORALPassive Reading
Passive reading at home
Sponsors
University of Magdeburg
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* clinical diagnosis of glaucoma * residual vision * the duration of the disease must be at least 6 months old * the visual field defect must be stable
Exclusion criteria
* autoimmune diseases in the acute stage * neurological and mental diseases * diabetic retinopathy * addictions * hypertension (maximum 160/100 mmHg) * retinitis pigmentosa- * pathological nystagmus * non-distant tumors or recurrent tumors * photosensitivity * pregnancy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual field size determined by perimetry measurements | 4 weeks | Changes of the visual field's size, evaluated by static perimetry and high resolution perimetry measurements |
| Microsaccade measurements | 4 weeks | Changes in the deviation of eye movements when visual targets are followed, using a computerized test |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Blood circulation in the eye | 4 weeks | Changes of the diameter of blood vessels in the eye, measured by vessel analysis |
| EEG connectivities | 4 weeks | Changes in alpha power using EEG recording (128 channels) |
Countries
Germany
Contacts
Primary ContactBernhard A Sabel, PhD
Outcome results
None listed